IP Library › Granted Patent US 11,253,833
Granted Patent B2
US 11,253,833 · App. 16/475,214 · Granted Feb 22, 2022

System and method for industrial encapsulation of thermolabile substances

Inventors: José María Lagaron Cabello (Paterna, ES); Sergio Castro Reina (Paterna, ES); José Manuel Valle (Paterna, ES); David Galan Nevado (Paterna, ES)
Assignees: BIOINICIA, S.L.; CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
B01J13/043A61K9/5042A61K9/5063A61K9/5089B01J2/02F26B3/08F26B3/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,253,833
App. No.
16/475,214
Granted
Feb 22, 2022
Kind
B2
Abstract

A facility for industrial drying and/or encapsulation of thermolabile substances comprising at least one injection unit ( 1 ) wherein the thermolabile substance is introduced, an encapsulating material when the facility is used to encapsulate, a solvent, additives and an injection gas flow for obtaining droplets from the thermolabile substance. It further comprises a drying unit ( 2 ) through which the droplets and a drying gas are introduced for evaporating the solvent and comprises a collection unit ( 3 ) configured to separate the microcapsules generated from the drying gas and which is selected from a cartridge filter collector, a cyclone collector or a combination of the two. It also describes a method for the industrial encapsulation of thermolabile substances which is carried out at the proposed facility.

Claims (27)

1. A method for the industrial encapsulation of thermolabile substances characterised in that it is carried out in a facility for industrial drying and/or encapsulation of thermolabile substances comprising at least:

one injection unit comprising at least:

one inlet for a solution;

one inlet for injection gas; and

one outlet for droplets through which sprayed droplets of solution are released,

one drying unit arranged after the injection unit and comprising at least:

one inlet for drying gas;

one inlet for droplets;

one longitudinal receptacle through which the droplets with the drying gas move until the solvent of the droplets evaporates, forming microcapsules; and

one outlet for microcapsules and drying gas through which the microcapsules and drying gas that drags the evaporated solvent with it are released from the receptacle;

one collection unit arranged after the drying unit, which is configured to separate the microcapsules generated from the drying gas;

wherein the method comprises the following stages:

a) preparing a polymer solution comprising:

a thermolabile substance to be encapsulated,

an encapsulating precursor;

an organic or aqueous solvent selected from ethanol, water and a combination thereof; and

b) forming droplets from a polymer solution obtained in stage (a) in the presence of an injection gas flow;

c) drying the droplets obtained in stage (b) in the drying unit at a controlled temperature to obtain microcapsules; and

d) collecting the microcapsules obtained in stage (c) by means of the collection unit; and wherein the stage b) of forming droplets is carried out by applying a voltage of between 0.1 kV and 500 kV to the solution and injection gas flow at the outlet of the injection unit.

2. The method of claim 1 , wherein the stage c) is carried out at ambient or sub-ambient temperature.

3. The method of claim 1 , wherein the encapsulating precursor of stage (a) is selected from animal, vegetable and microbial proteins.

4. The method of claim 3 , wherein the encapsulating precursor of stage (a) is selected from milk serum, caseins, natural polypeptides or obtained from the genetic modification of microorganisms, collagen, soy protein and zein.

5. The method of claim 1 , wherein the encapsulating precursor of stage (a) are oligosaccharides selected from lactose, sucrose, maltose and fructo-oligosaccharides.

6. The method of claim 1 wherein an additive is used in stage a).

7. The method of claim 6 , wherein the additive is a surfactant.

8. The method of claim 1 , wherein the stage b) of forming droplets is carried out by applying a voltage of between 5 kV and 15 kV to the solution and injection gas flow at the outlet of the injection unit.

9. The method of claim 1 , wherein the stage b) of forming droplets is carried out by applying a voltage in alternating current.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2025
From: BIOINICIA, S.L.
To: BIONANOPHARMA S.L.
Reel/Frame 072509/0961 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2020
From: LAGARON CABELLO, JOSE MARIA; GALAN NEVADO, DAVID
To: BIOINICIA, S.L.; CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Reel/Frame 051952/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2020
From: VALLE, JOSE MANUEL
To: BIOINICIA, S.L.; CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Reel/Frame 052045/0409 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2020
From: CASTRO REINA, SERGIO
To: BIOINICIA, S.L.; CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Reel/Frame 052048/0268 →
Priority Claims (1)
ES ES201631725 · Dec 30, 2016 · national
Continuity (1)
Related Publication 20190336931A1 · Nov 7, 2019
Cited By (2)
US 12,201,134 US 12,419,838